Literature DB >> 11281474

Inadequate repeatability of the one-hour pad test: the need for a new incontinence outcome measure.

A M Simons1, W C Yoong, S Buckland, K H Moore.   

Abstract

OBJECTIVE: To assess the reproducibility of two one-hour pad tests performed within one week using serial ultrasound scanning to obtain identical bladder volumes, and to measure the effect of patient anxiety upon test reproducibility.
DESIGN: Prospective observational study.
SETTING: Tertiary urogynaecological unit. SAMPLE: Fifty-six incontinent women undergoing 112 pad tests.
METHOD: Two one-hour pad tests were performed with natural diuresis one week apart prior to treatment. At the second test, serial ultrasound scans were performed until bladder volume reached that of the first test, followed by identical provocation. MAIN OUTCOME MEASURES: One-hour pad loss, bladder volumes (Vol1, Vol2), anxiety VAS questionnaire.
RESULTS: Despite serial scanning, bladder volumes differed significantly. Median volume before second pad test was 541 mL, compared with 433 mls before first test (P < 0.001). The second pad test was also significantly larger than first (median 16g vs 4g, P = 0.017), and 13/56 (23%) women were dry on the first test but incontinent on the second. In 26 women (46%) both bladder volumes were similar, but the second pad loss was still significantly greater (median 14g vs 4g, P = 0.037). The mean difference between tests was 10g and the limits of agreement were wide (ranging from -44 to +66 g difference for the test result). Women were more anxious about leaking during the first test (Median VAS during the first test was 2.8cm, compared with 0.6cm during the second test, P = 0.008). 42.5% found the second test to be more typical.
CONCLUSION: In women with similar bladder volumes, the test-retest reliability of the one-hour pad test was judged to be clinically inadequate, as the first and second pad test could differ by -44 to +66g. Lower anxiety levels at the second test may account for this finding. The one-hour pad test is a useful baseline measure of incontinence, but the poor repeatability suggests that is not an optimal measure of post-treatment change.

Entities:  

Mesh:

Year:  2001        PMID: 11281474     DOI: 10.1111/j.1471-0528.2001.00069.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  10 in total

1.  The repeatability of the 24-hour pad test.

Authors:  E Karantanis; W Allen; T L Stevermuer; A M Simons; R O'Sullivan; K H Moore
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-07-07

2.  Self-reported pad use per day reflects patient quality of life after pubovaginal sling surgery.

Authors:  John T Stoffel; Gjange Smith; Simone Crivellaro; John J Smith; John F Bresette
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-01

3.  Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency).

Authors:  Adrian Gaspar; Hugo Brandi
Journal:  Lasers Med Sci       Date:  2017-02-16       Impact factor: 3.161

4.  Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial.

Authors:  Zhishun Liu; Yan Liu; Huanfang Xu; Liyun He; Yuelai Chen; Lixin Fu; Ning Li; Yonghui Lu; Tongsheng Su; Jianhua Sun; Jie Wang; Zenghui Yue; Wei Zhang; Jiping Zhao; Zhongyu Zhou; Jiani Wu; Kehua Zhou; Yanke Ai; Jing Zhou; Ran Pang; Yang Wang; Zongshi Qin; Shiyan Yan; Hongjiao Li; Lin Luo; Baoyan Liu
Journal:  JAMA       Date:  2017-06-27       Impact factor: 56.272

Review 5.  Outcome measures for stress urinary incontinence treatment: can we minimally agree?

Authors:  Véronique Phé; Philippe Zimmern; Emmanuel Chartier-Kastler
Journal:  World J Urol       Date:  2015-03-20       Impact factor: 4.226

6.  Lower urinary tract symptoms after total and subtotal hysterectomy: results of a randomized controlled trial.

Authors:  Helga Gimbel; Vibeke Zobbe; Birthe Jakobsen Andersen; Helle Christina Sørensen; Kim Toftager-Larsen; Katrine Sidenius; Nini Møller; Ellen Merete Madsen; Mogens Vejtorp; Helle Clausen; Annie Rosgaard; John Villumsen; Christian Gluud; Bent S Ottesen; Ann Tabor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005 Jul-Aug

7.  Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women.

Authors:  Ph H ter Meulen; L C M Berghmans; F H M Nieman; Ph E V A van Kerrebroeck
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-10-21

8.  Comparison of the ICIQ-SF and 24-hour pad test with other measures for evaluating the severity of urodynamic stress incontinence.

Authors:  Emmanuel Karantanis; Michelle Fynes; Kate H Moore; Stuart L Stanton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-01-31

9.  An Effective Meta-analysis of Magnetic Stimulation Therapy for Urinary Incontinence.

Authors:  Qing He; Kaiwen Xiao; Liao Peng; Junyu Lai; Hong Li; Deyi Luo; Kunjie Wang
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

10.  Test-retest reliability of the 20-min pad test with infusion of strong-desired volume in the bladder for female urodynamic stress incontinence.

Authors:  Wen-Yih Wu; Sheng-Mou Hsiao; Pei-Chi Wu; Ho-Hsiung Lin
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.